AlphaYouAC
Insider selling
Adam Crystal sold $962K of Tango Therapeutics, Inc. (TNGX) stock
Adam Crystal, President, R&D of Tango Therapeutics, Inc. (TNGX), sold 38,460 shares of TNGX stock worth $962K, per an SEC Form 4 filed Apr 16, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Apr 15, 2026, 1 day before it was made public.
TNGX has moved -11.8% since the trade date, from $25.33 to $22.33 (Sep 21, 2026 close).
- Traded
- Apr 15, 2026
- Disclosed
- Apr 16, 2026
- Filing delay
- 1 day
- Price since
- -11.8%
- Role
- President, R&D
- Source
- SEC Form 4
More TNGX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.